Cargando…
The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
This piece introduces the JME symposium ‘The benefit/risk ratio challenge in clinical research, and the case of HIV cure.’
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121082/ https://www.ncbi.nlm.nih.gov/pubmed/27215763 http://dx.doi.org/10.1136/medethics-2016-103427 |
_version_ | 1782469339512832000 |
---|---|
author | Eyal, Nir |
author_facet | Eyal, Nir |
author_sort | Eyal, Nir |
collection | PubMed |
description | This piece introduces the JME symposium ‘The benefit/risk ratio challenge in clinical research, and the case of HIV cure.’ |
format | Online Article Text |
id | pubmed-5121082 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-51210822017-02-01 The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction Eyal, Nir J Med Ethics Introduction This piece introduces the JME symposium ‘The benefit/risk ratio challenge in clinical research, and the case of HIV cure.’ BMJ Publishing Group 2017-02 2016-05-23 /pmc/articles/PMC5121082/ /pubmed/27215763 http://dx.doi.org/10.1136/medethics-2016-103427 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Introduction Eyal, Nir The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title | The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title_full | The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title_fullStr | The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title_full_unstemmed | The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title_short | The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction |
title_sort | benefit/risk ratio challenge in clinical research, and the case of hiv cure: an introduction |
topic | Introduction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121082/ https://www.ncbi.nlm.nih.gov/pubmed/27215763 http://dx.doi.org/10.1136/medethics-2016-103427 |
work_keys_str_mv | AT eyalnir thebenefitriskratiochallengeinclinicalresearchandthecaseofhivcureanintroduction AT eyalnir benefitriskratiochallengeinclinicalresearchandthecaseofhivcureanintroduction |